| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/26/1999 | CA2263703A1 A process for producing enteric coated pancreatin granules |
| 08/25/1999 | EP0937982A2 Diagnostic and therapeutic agent for treatment of autoimmune hepatitis |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937734A1 11-Acetyl-12,13-dioxabicyclo [8.2.1] tridecenone derivatives, process for making them and pharmaceutical compositions containing them |
| 08/25/1999 | EP0937726A1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates |
| 08/25/1999 | EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors |
| 08/25/1999 | EP0937718A1 Antibiotic tkr2648 and process for producing the same |
| 08/25/1999 | EP0937708A2 sulphonamide derivatives |
| 08/25/1999 | EP0937464A2 Combined pharmaceutical preparation containing inhibitors of the sodium hydrogen exchange and a medicament for the treatment of cardiovascular diseases |
| 08/25/1999 | EP0937460A2 Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions |
| 08/25/1999 | EP0937459A2 Pharmaceutical compositions for the treatment of ischemic brain damage |
| 08/25/1999 | EP0937458A2 Pyrrolidine and piperidine derivatives |
| 08/25/1999 | EP0937457A1 Remedies for allergic dermatitis |
| 08/25/1999 | EP0937395A1 Disinfecting and sterilizing concentrate containing an aromatic dialdehyde and a neutral ph buffering system |
| 08/25/1999 | EP0937394A1 Antimicrobial composition |
| 08/25/1999 | EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/25/1999 | EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 08/25/1999 | EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 08/25/1999 | EP0937102A1 Human monocyte chemotactic proprotein |
| 08/25/1999 | EP0937100A1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof |
| 08/25/1999 | EP0937099A1 Oligomers which inhibit the expression of interleukin genes |
| 08/25/1999 | EP0937093A2 1-galactose derivatives |
| 08/25/1999 | EP0937092A1 Solid support matrices containing a toxin binding oligosaccharide |
| 08/25/1999 | EP0937089A1 New knoevenagel condensation products, method for their production and their use |
| 08/25/1999 | EP0937085A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 08/25/1999 | EP0937084A1 Process for the preparation of salts and esters of clavulanic acid |
| 08/25/1999 | EP0937083A1 A crystalline substance of cefditoren pivoxyl and the production of the same |
| 08/25/1999 | EP0937079A1 Stabilized carbapenem antibiotic compositions and method of making |
| 08/25/1999 | EP0937078A1 Tricyclic carbapenem compounds |
| 08/25/1999 | EP0937077A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 08/25/1999 | EP0937076A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/25/1999 | EP0937075A1 New imidazopyridines and oxazolopyridines |
| 08/25/1999 | EP0937074A1 Benzonaphthyridines as bronchial therapeutics |
| 08/25/1999 | EP0937072A1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABA A? $g(a)5 RECEPTOR SUBTYPE |
| 08/25/1999 | EP0937071A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole |
| 08/25/1999 | EP0937070A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 08/25/1999 | EP0937069A1 Piperazino derivatives as neurokinin antagonists |
| 08/25/1999 | EP0937067A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors |
| 08/25/1999 | EP0937066A1 (4r,5s,6s,7r)-hexahydro-1- 5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis phenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor |
| 08/25/1999 | EP0937065A1 Constrained somatostatin agonists and antagonists |
| 08/25/1999 | EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists |
| 08/25/1999 | EP0937063A1 Aryloxypropanolamine derivatives, method of preparation and applications thereof |
| 08/25/1999 | EP0937062A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937061A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937060A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937059A1 NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937058A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937057A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 08/25/1999 | EP0937054A1 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 08/25/1999 | EP0937053A1 Sustained-release derivatives of hydroxylated analogs of substituted 1- 2 bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake |
| 08/25/1999 | EP0937048A1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 08/25/1999 | EP0937047A1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 08/25/1999 | EP0937046A2 Substituted 3-benzylpyrazoles and their use as herbicides and for lowering the sugar content in blood |
| 08/25/1999 | EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 08/25/1999 | EP0937044A1 Cftr channel activator compounds and pharmaceutical compositions containing same |
| 08/25/1999 | EP0937043A1 Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them |
| 08/25/1999 | EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 08/25/1999 | EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 08/25/1999 | EP0937040A2 N-substituted 2-cyanopyrrolidines |
| 08/25/1999 | EP0937038A1 Vitamin d analogues |
| 08/25/1999 | EP0937037A1 Sodium salt of poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0937035A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| 08/25/1999 | EP0937032A1 Substituted gamma aminobutyric acids as pharmaceutical agents |
| 08/25/1999 | EP0937030A1 3-amino-propoxyphenyl derivatives (i) |
| 08/25/1999 | EP0936924A2 Pharmaceutical composition containing a 5ht 2c? antagonist and a d 2? antagonist |
| 08/25/1999 | EP0936916A1 Cosmetic compositions |
| 08/25/1999 | EP0936915A1 Chelating agents and their metal chelates for treating free radicals induced conditions |
| 08/25/1999 | EP0936914A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 08/25/1999 | EP0936913A1 Oral pharmaceutical preparation containing ibandronat |
| 08/25/1999 | EP0936912A1 Inhibitors of cysteine protease |
| 08/25/1999 | EP0936911A1 Adenosine deaminase inhibitors |
| 08/25/1999 | EP0936910A2 Intracoronary stents containing quinazolinone derivatives |
| 08/25/1999 | EP0936909A1 Pharmaceutical composition for treating viral diseases |
| 08/25/1999 | EP0936908A1 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als) |
| 08/25/1999 | EP0936907A2 Pharmaceutical preparation |
| 08/25/1999 | EP0936906A1 Reflux inhibitors |
| 08/25/1999 | EP0936902A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy |
| 08/25/1999 | EP0936901A1 Pharmaceutical composition for rapid suspension in aqueous media |
| 08/25/1999 | EP0936900A2 Aqueous, antimicrobial liquid cleaning formulation |
| 08/25/1999 | EP0936897A1 Composition having tanning and sun-screening activity, and cosmetic uses thereof |
| 08/25/1999 | EP0936896A1 Cosmetic compositions |
| 08/25/1999 | EP0936866A1 Compounds, compositions and methods for treating antibiotic-resistant infections |
| 08/25/1999 | EP0921774A4 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 08/25/1999 | EP0839036B1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
| 08/25/1999 | EP0751934B1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 08/25/1999 | EP0749430B1 Thiazolidinedione derivatives as anti-hyperglycemic agents |
| 08/25/1999 | EP0723451B1 Use of lithium compounds in combination with ace-inhibitors and/or angiotensin ii -receptor antagonist for treating high blood pressure |
| 08/25/1999 | EP0700290B1 Rectal compositions containing odansetron in its free base form |
| 08/25/1999 | EP0667858B1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists |
| 08/25/1999 | EP0661967B1 Combined virustatic antimediator (covam) treatment of common colds |
| 08/25/1999 | EP0650483B1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS |
| 08/25/1999 | EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
| 08/25/1999 | EP0572494B1 Composition for use in transdermal administration |
| 08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
| 08/25/1999 | CN1226933A Method for preparing polydispersed saccharide composition and resulting polydispersed saccharide composition |
| 08/25/1999 | CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 08/25/1999 | CN1226899A Synthetic IL-10 analogues |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/25/1999 | CN1226893A Selected derivatives of K-252a |